BEYOND PROGNOSIS: LONGITUDINAL DYNAMICS OF THE NEUTROPHIL-TO-LYMPHOCYTE RATIO DRIVEN BY RADIATION-INDUCED LYMPHOPENIA DURING RADIOTHERAPY FOR HEAD AND NECK CANCER
- 1Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HC-FMRP-USP), Ribeirão Preto, SP, Brazil
Abstract
Introduction: Head and neck squamous cell carcinoma (HNSCC) is commonly treated with intensity-modulated radiotherapy (IMRT). IMRT frequently induces treatment-related lymphopenia, potentially disrupting systemic immune homeostasis. The neutrophil-to-lymphocyte ratio (NLR), a widely used prognostic biomarker in oncology, may therefore reflect radiation-induced immune imbalance rather than systemic inflammation alone. However, the longitudinal behavior of neutrophils, lymphocytes, and NLR during IMRT remains poorly characterized. Objective: To prospectively evaluate longitudinal shifts in neutrophil and lymphocyte dynamics via NLR during IMRT for HNSCC and explore their association with clinical outcomes. Methods: A prospective observational study included patients with HNSCC treated with IMRT (≥50 Gy involving the oral cavity). Patients who did not complete radiotherapy failed to adhere to institutional oral supportive care, or discontinued treatment were excluded. Before IMRT, all patients underwent comprehensive dental management, including elimination of oral infectious foci, extraction of hopeless teeth, periodontal therapy, and oral hygiene instruction. During IMRT, patients underwent oral evaluations 3-times weekly and received preventive photobiomodulation therapy for oral mucositis (660-nm red laser, 100 mW, beam area 0.098 cm 2 , power density 1.02 W/cm 2 , 10.20 J/cm 2 , 10s/point). Peripheral blood samples were collected immediately before IMRT (T0), during the fourth treatment week (T1), and one week after treatment completion (T2). Longitudinal changes were analyzed using Friedman and paired Wilcoxon tests. Associations with overall survival were explored using Cox regression adjusted for age and tumor stage. The study was approved by the institutional Research Ethics Committee (CAAE: 65662422.9.0000.5440). Results: Thirty patients were included (median age, 57-years [IQR, 53.3–65.3]); 83.3% were male, 76.7% had stage III/IV disease, and 60.0% received concurrent cisplatin-based chemoradiotherapy. After a median follow-up of 17.5-months, 40.0% died and 43.3% developed recurrence. NLR significantly increased during treatment (p<0.001), from median of 1.94 at T0 to 6.12 at T1 and remaining elevated at T2 (5.59). This increase was predominantly driven by a marked decline in lymphocyte counts (median 2.10, 0.60, and 0.65 × 10⁹/L at T0, T1, and T2, respectively; p<0.001), whereas neutrophil counts remained relatively stable (p=0.196). Neither NLR nor absolute neutrophil counts were independently associated with overall survival after adjustment for age and tumor stage. Discussion: The marked and sustained elevation of NLR during and shortly after IMRT reflects an acute homeostatic imbalance between systemic innate response and adaptive immunity. Rather than isolated neutrophilia, this shift is predominantly propelled by treatment-related lymphocyte consumption ‒ a hallmark of radiation-induced lymphopenia. This proportional loss of lymphocytes over neutrophils impairs host immunosurveillance during active treatment. Although not powered to establish survival associations, these findings characterize the kinetic window of therapy-induced immune dysregulation. Conclusion: These findings suggest that longitudinal NLR changes during IMRT are predominantly lymphopenia-driven and provide a rationale for future studies investigating radiation-induced immune alterations and their clinical implications.
Related
- Delayed elective nodal irradiation in head-and-neck cancer radiotherapy reduces acute lymphocyte damage, lymphopenia, and modulates immune signatures
- Beyond Prognosis: A Systematic Review of the Neutrophil-to-Lymphocyte Ratio as a Modifiable Cardiovascular Biomarker
- Acute Lymphopenia and Recovery With Prophylactic Pelvic Nodal Radiotherapy in Oligometastatic Prostate Cancer: Interim Results From the Prospective PROLONG2 Cohort.
- Nonlinear associations of the neutrophil-to-lymphocyte ratio and derived neutrophil-to-lymphocyte ratio with asthma–COPD overlap prevalence: a cross-sectional study
- Neutrophil-to-Lymphocyte Ratio Identifies a Pulmonary Vascular High-Risk Phenotype in Heart Failure with Preserved Ejection Fraction
BibTeX
@article{eskenazi2026beyond,
title = {{BEYOND PROGNOSIS: LONGITUDINAL DYNAMICS OF THE NEUTROPHIL-TO-LYMPHOCYTE RATIO DRIVEN BY RADIATION-INDUCED LYMPHOPENIA DURING RADIOTHERAPY FOR HEAD AND NECK CANCER}},
author = {Ana Patricia Espaladori ESKENAZI and Milena Rodrigues VASCONCELOS and Mariana Andrade COSTA and Maria Júlia PAGLIARONE and Juliana Guaraldi SORRENTINO and Istefani Silva SOUZA and Larissa Eloy PEIXOTO and Tatiane Cardoso MOTTA and Murilo Kenji KAWASAKI and Hilton Marcos Alves RICZ and Leandro Dorigan MACEDO},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2026},
month = oct,
doi = {10.1016/j.htct.2026.108272},
url = {https://doi.org/10.1016/j.htct.2026.108272},
note = {CC BY},
}
RIS
TY - JOUR
TI - BEYOND PROGNOSIS: LONGITUDINAL DYNAMICS OF THE NEUTROPHIL-TO-LYMPHOCYTE RATIO DRIVEN BY RADIATION-INDUCED LYMPHOPENIA DURING RADIOTHERAPY FOR HEAD AND NECK CANCER
AU - Ana Patricia Espaladori ESKENAZI
AU - Milena Rodrigues VASCONCELOS
AU - Mariana Andrade COSTA
AU - Maria Júlia PAGLIARONE
AU - Juliana Guaraldi SORRENTINO
AU - Istefani Silva SOUZA
AU - Larissa Eloy PEIXOTO
AU - Tatiane Cardoso MOTTA
AU - Murilo Kenji KAWASAKI
AU - Hilton Marcos Alves RICZ
AU - Leandro Dorigan MACEDO
PY - 2026
DA - 2026/10/23
JO - Hematology, Transfusion and Cell Therapy
DO - 10.1016/j.htct.2026.108272
UR - https://doi.org/10.1016/j.htct.2026.108272
AB - Introduction: Head and neck squamous cell carcinoma (HNSCC) is commonly treated with intensity-modulated radiotherapy (IMRT). IMRT frequently induces treatment-related lymphopenia, potentially disrupting systemic immune homeostasis. The neutrophil-to-lymphocyte ratio (NLR), a widely used prognostic biomarker in oncology, may therefore reflect radiation-induced immune imbalance rather than systemic inflammation alone. However, the longitudinal behavior of neutrophils, lymphocytes, and NLR during IMRT remains poorly characterized. Objective: To prospectively evaluate longitudinal shifts in neutrophil and lymphocyte dynamics via NLR during IMRT for HNSCC and explore their association with clinical outcomes. Methods: A prospective observational study included patients with HNSCC treated with IMRT (≥50 Gy involving the oral cavity). Patients who did not complete radiotherapy failed to adhere to institutional oral supportive care, or discontinued treatment were excluded. Before IMRT, all patients underwent comprehensive dental management, including elimination of oral infectious foci, extraction of hopeless teeth, periodontal therapy, and oral hygiene instruction. During IMRT, patients underwent oral evaluations 3-times weekly and received preventive photobiomodulation therapy for oral mucositis (660-nm red laser, 100 mW, beam area 0.098 cm 2 , power density 1.02 W/cm 2 , 10.20 J/cm 2 , 10s/point). Peripheral blood samples were collected immediately before IMRT (T0), during the fourth treatment week (T1), and one week after treatment completion (T2). Longitudinal changes were analyzed using Friedman and paired Wilcoxon tests. Associations with overall survival were explored using Cox regression adjusted for age and tumor stage. The study was approved by the institutional Research Ethics Committee (CAAE: 65662422.9.0000.5440). Results: Thirty patients were included (median age, 57-years [IQR, 53.3–65.3]); 83.3% were male, 76.7% had stage III/IV disease, and 60.0% received concurrent cisplatin-based chemoradiotherapy. After a median follow-up of 17.5-months, 40.0% died and 43.3% developed recurrence. NLR significantly increased during treatment (p<0.001), from median of 1.94 at T0 to 6.12 at T1 and remaining elevated at T2 (5.59). This increase was predominantly driven by a marked decline in lymphocyte counts (median 2.10, 0.60, and 0.65 × 10⁹/L at T0, T1, and T2, respectively; p<0.001), whereas neutrophil counts remained relatively stable (p=0.196). Neither NLR nor absolute neutrophil counts were independently associated with overall survival after adjustment for age and tumor stage. Discussion: The marked and sustained elevation of NLR during and shortly after IMRT reflects an acute homeostatic imbalance between systemic innate response and adaptive immunity. Rather than isolated neutrophilia, this shift is predominantly propelled by treatment-related lymphocyte consumption ‒ a hallmark of radiation-induced lymphopenia. This proportional loss of lymphocytes over neutrophils impairs host immunosurveillance during active treatment. Although not powered to establish survival associations, these findings characterize the kinetic window of therapy-induced immune dysregulation. Conclusion: These findings suggest that longitudinal NLR changes during IMRT are predominantly lymphopenia-driven and provide a rationale for future studies investigating radiation-induced immune alterations and their clinical implications.
SN - 2531-1379
SN - 2531-1387
ER -